Update in Kidney Transplantation
Einstein-Montefiore Department of Medicine Grand Rounds
Thursday, March 11, 2010
First Floor Lecture Hall, Forchheimer/Einstein
Cherkasky Auditorium, Moses/Montefiore
Image: Enver Akalin, MD
Enver Akalin, MD
Professor of Clinical Medicine
Albert Einstein College of Medicine
Medical Director, Kidney and Pancreas Transplantation
Montefiore Medical Center
As a UNOS-certified transplant nephrologist, Dr. Enver Akalin brings to Montefiore more than a decade of expertise in kidney and kidney-pancreas transplantation. Prior to joining Montefiore, Dr. Akalin served as the medical director of the Kidney and Pancreas Transplantation Program and as the director of the Transplant Nephrology Fellowship at Mount Sinai School of Medicine.
Dr. Akalin has served on the American Society of Transplantation Clinical Trials Committee and the Renal Accreditation Committee; the American Society of Nephrology Transplant Advisory Group; and the Medical Board of New York Organ Donor Network. He currently serves on the Editorial Board of the Clinical Journal of the American Society of Nephrology. Dr. Akalin has been the principal investigator in several trials, and has written numerous articles on complex issues in kidney transplantation.
Dr. Akalin's main research interest is investigating mechanisms of acute and chronic rejection using microarray technology and immune monitoring of kidney transplant recipients. He is one of the first investigators to apply GeneChip (microarray) technology in human kidney transplantation. GeneChip is a powerful technology that detects thousands of genes simultaneously and might help to understand the mechanisms, diagnosis, and the treatment of complex disease, such as rejection of the kidney transplant. His other main research interest is kidney transplantation in highly sensitized cross-match positive or blood group incompatible kidney transplant recipients by using desensitization protocols with Intravenous Immunoglobulin, Rituximab, and Plasmapheresis. He investigates the mechanisms of desensitization treatment and its effect on donor-specific antibodies. He is also involved in multicenter trials of new immunosuppressive medications.
Dr. Akalin earned his medical degree at Ege University School of Medicine in Izmir, Turkey. He completed a research fellowship in the Renal Division at Brigham and Woman’s Hospital, Harvard Medical School, followed by a clinical fellowship in the Renal Division at Boston University School of Medicine. He completed his residency in Internal Medicine as well as a clinical transplant nephrology fellowship in the Renal Division at Emory University School of Medicine.
This grand rounds is hosted by the Division of Nephrology.
After attending this activity, participants will be able to:
Understand the clinical outcomes in kidney transplantation including patient and graft survival, acute and chronic rejection rate
Describe pretransplant immunologic risk assessment
Review current obstacles in transplantation to reach a better outcome
Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.